Structure–activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (12) , 3491-3494
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01CA122608)
This publication has 24 references indexed in Scilit:
- Haspin: a newly discovered regulator of mitotic chromosome behaviorChromosoma, 2009
- Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organizationProceedings of the National Academy of Sciences, 2009
- Structure and functional characterization of the atypical human kinase haspinProceedings of the National Academy of Sciences, 2009
- Studies of haspin-depleted cells reveal that spindle-pole integrity in mitosis requires chromosome cohesionJournal of Cell Science, 2009
- Regulation of MBK-2/DYRK by CDK-1 and the Pseudophosphatases EGG-4 and EGG-5 during the Oocyte-to-Embryo TransitionCell, 2009
- Identification of Small Molecule Inhibitors of the Mitotic Kinase Haspin by High-Throughput Screening Using a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer AssaySLAS Discovery, 2008
- Role for DYRK family kinases on regulation of apoptosisBiochemical Pharmacology, 2008
- Mitotic phosphorylation of histone H3 at threonine 3FEBS Letters, 2004
- The Haspin gene: location in an intron of the Integrin αE gene, associated transcription of an Integrin αE-derived RNA and expression in diploid as well as haploid cellsGene, 2001
- Isolation and characterization of cDNA clones specifically expressed in testicular germ cellsFEBS Letters, 1994